ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PTGX Protagonist Therapeutics Inc

30.74
-1.20 (-3.76%)
17 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 859k0000060M254.95M
Operating Income -41.44M-32.3M-36.52M-36.02M-42.35M-38.33M23.05M206.31M
Pre Tax Income -41.04M-31.23M-34.19M-33.73M-38.46M-34.11M27.34M210.67M
Net Income -41.04M-31.23M-34.19M-33.73M-38.46M-34.11M27.34M207.34M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -41.51M-32.39M-36.45M-36.22M-42.37M-38.36M23.09M206.29M
EBITDA -41.18M-32.03M-36.26M-35.77M-42.12M-38.08M23.3M206.55M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 020.06M30.93M231k28.63M27.36M26.58M60M
Operating Income -32.67M-37.9M-42.27M-80.52M-64.52M-125.85M-131.37M-93.65M
Pre Tax Income -37.18M-36.96M-39.72M-77.88M-64.85M-125.55M-127.39M-78.96M
Net Income -37.74M-36.96M-38.92M-77.19M-66.15M-125.55M-127.39M-78.96M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.257-1.753-1.679-2.836-1.512-2.625-2.582-1.369
EBIT -32.7M-37.9M-42.27M-80.52M-65.15M-125.99M-131.45M-93.85M
EBITDA -32.35M-37.49M-41.74M-79.82M-63.73M-125.03M-130.34M-92.68M